{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:37:02Z","timestamp":1707525422580},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,29]]},"DOI":"10.7759\/cureus.47927","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T03:22:13Z","timestamp":1698636133000},"source":"Crossref","is-referenced-by-count":0,"title":["Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis"],"prefix":"10.7759","author":[{"given":"Durga","family":"Deorukhkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Sonawale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshitij","family":"Sonawale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier RW","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rod\u00e9s J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatol. 1988, 8:1151-7. 10.1002\/hep.1840080532","journal-title":"Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli P","year":"2006","unstructured":"Angeli P, Wong F, Watson H, Gin\u00e8s P. Hyponatremia in cirrhosis: results of a patient population survey. Hepatol. 2006, 44:1535-42. 10.1002\/hep.21412","journal-title":"Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s A","year":"1993","unstructured":"Gin\u00e8s A, Escorsell A, Gin\u00e8s P, et al.. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterol. 1993, 105:229-36. 10.1016\/0016-5085(93)90031-7","journal-title":"Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.96","article-title":"Management of hepatorenal syndrome in patients with cirrhosis","volume":"7","author":"Arroyo V","year":"2011","unstructured":"Arroyo V, Fern\u00e1ndez J. Management of hepatorenal syndrome in patients with cirrhosis. Nat Rev Nephrol. 2011, 7:517-26. 10.1038\/nrneph.2011.96","journal-title":"Nat Rev Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc M","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatol. 2000, 31:864-71. 10.1053\/he.2000.5852","journal-title":"Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo V","year":"1996","unstructured":"Arroyo V, Gin\u00e8s P, Gerbes AL, et al.. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatol. 1996, 23:164. 10.1002\/hep.510230122","journal-title":"Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ygh2.429","article-title":"Predicting mortality for hepatorenal syndrome with liver-specific scores","volume":"2","author":"Zulian Terres A","year":"2020","unstructured":"Zulian Terres A, Sartori Balbinot R, Laura Facco Muscope A, et al.. Predicting mortality for hepatorenal syndrome with liver-specific scores. GastroHep. 2020, 2:336-43. 10.1002\/ygh2.429","journal-title":"GastroHep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12968\/gasn.2013.11.7.29","article-title":"The pathophysiology of hepatorenal syndrome","volume":"11","author":"Gipson A","year":"2013","unstructured":"Gipson A. The pathophysiology of hepatorenal syndrome. Gastrointest Nurs. 2013, 11:29-35. 10.12968\/gasn.2013.11.7.29","journal-title":"Gastrointest Nurs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort P","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, et al.. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999, 341:403-9. 10.1056\/NEJM199908053410603","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2015.010","article-title":"Predictors of hepatorenal syndrome in alcoholic liver cirrhosis","volume":"159","author":"Janicko M","year":"2015","unstructured":"Janicko M, Veseliny E, Senajova G, Jarcuska P. Predictors of hepatorenal syndrome in alcoholic liver cirrhosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015, 159:661-5. 10.5507\/bp.2015.010","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez J","year":"2007","unstructured":"Fern\u00e1ndez J, Navasa M, Planas R, et al.. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterol. 2007, 133:818-24. 10.1053\/j.gastro.2007.06.065","journal-title":"Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14660","article-title":"Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy","volume":"40","author":"Greinert R","year":"2020","unstructured":"Greinert R, Zipprich A, Sim\u00f3n-Talero M, et al.. Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy. Liver Int. 2020, 40:3093-102. 10.1111\/liv.14660","journal-title":"Liver Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli P","year":"2015","unstructured":"Angeli P, Gines P, Wong F, et al.. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015, 64:531-7. 10.1136\/gutjnl-2014-308874","journal-title":"Gut"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh V","year":"2012","unstructured":"Singh V, Ghosh S, Singh B, et al.. Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study. J Hepatol. 2012, 56:1293-8. 10.1016\/j.jhep.2012.01.012","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)24010-9","article-title":"Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome","volume":"349","author":"Brensing KA","year":"1997","unstructured":"Brensing KA, Textor J, Strunk H, Klehr HU, Schild H, Sauerbruch T. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet. 1997, 349:697-8. 10.1016\/S0140-6736(97)24010-9","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti AS","year":"2018","unstructured":"Allegretti AS, Parada XV, Eneanya ND, et al.. Prognosis of patients with cirrhosis and AKI who initiate RRT. Clin J Am Soc Nephrol. 2018, 13:16-25. 10.2215\/CJN.03610417","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/192537-deranged-biochemical-markers-as-early-predictors-for-the-development-of-hepatorenal-syndrome-in-patients-with-alcoholic-liver-cirrhosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:06Z","timestamp":1707509346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/192537-deranged-biochemical-markers-as-early-predictors-for-the-development-of-hepatorenal-syndrome-in-patients-with-alcoholic-liver-cirrhosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,29]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.47927","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,29]]}}}